A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Chronic Hepatitis B Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

AusperBio Investigational Site, Ch’ang-ch’un, Jilin, China
Contact: Study coordinator (Bella Lu) · clinicaltrial@ausperbio.com · 0571-86959519
Contact: Principal Investigator (Yanhua Ding)
Contact: Principal Investigator (Junqi Niu)
AusperBio Investigational Site, Hangzhou, Zhejiang, China
Contact: Study coordinator (Bella Lu) · clinicaltrial@ausperbio.com · 0571-86959519
陆 · clinicaltrial@ausperbio.com

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B

Chronic Hepatitis b

Abroad (travel likely)Recruiting

Shanghai, China

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

Chronic Hepatitis B

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

Chronic Hep B · Chronic Hepatitis b · Chronic Hepatitis

Abroad (travel likely)RecruitingPHASE1

Hong Kong, Hong Kong · Chisinau, Moldova

A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults

Chronic Hepatitis B Infection

Abroad (travel likely)RecruitingPHASE1

Herston, Australia